Get started
Author

Stefano Buttò

Observed names: S Butto, S Buttò, S Buttó, S. BUTTÓ, S. Butto, S. Buttò, STEFANO BUTTÒ, Stefano Butto, Stefano Buttò, Stefano Butto’, Stefano Buttó, Stephano Butto
Observed institutions: South African Medical Research Council, National Institutes of Health, University of Milan, Istituto Superiore di Sanità, Duke Medical Center, Max Planck Institute of Biochemistry, University of Naples Federico II, Sapienza University of Rome
ORCID: 0000-0002-3289-2686
Observed ORCID: 0000-0002-3289-2686
OpenAlex ID: A5033450659
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
2018 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet Infectious Diseases · 406
PDF
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
1999 · Aurelio Cafaro, Antonella Caputo, et al. · Nature Medicine · 276
PDF
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma.
1999 · P Monini, S Colombini, et al. · PubMed · 189
HIV virology and pathogenetic mechanisms of infection: a brief overview
2010 · Emanuele Fanales-Belasio, Mariangela Raimondo, et al. · Annali dell Istituto Superiore di Sanità · 183
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)
2001 · Aurelio Cafaro, Fausto Titti, et al. · Vaccine · 145
Immune activation in Africa is environmentally-driven and is associated with upregulation of CCR5
2000 · Mario Clerici, Stefano Butto, et al. · AIDS · 124
The Presence of Anti‐Tat Antibodies Is Predictive of Long‐Term Nonprogression to AIDS or Severe Immunodeficiency: Findings in a Cohort of HIV‐1 Seroconverters
2005 · Giovanni Rezza, Valeria Fiorelli, et al. · The Journal of Infectious Diseases · 115
PDF
Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains.
1991 · F Grassi, R Meneveri, et al. · The Journal of Experimental Medicine · 102
PDF
Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections
1998 · Giovanni Rezza, Evelyne T. Lennette, et al. · International Journal of Cancer · 99
PDF
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: a systematic review and global survey
2020 · Joris Hemelaar, Ramyiadarsini Elangovan, et al. · The Lancet HIV · 98
Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in Endothelial Cells and Induction of Vascular Permeability In Vivo by Human Immunodeficiency Virus-1 Tat Protein and Basic Fibroblast Growth Factor
2001 · Elena Toschi, Giovanni Barillari, et al. · Molecular Biology of the Cell · 90
PDF
Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells
1999 · Paolo Monini, Francesca Carlini, et al. · Journal of Virology · 83
PDF
Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys
2004 · Maria Teresa Maggiorella, Silvia Baroncelli, et al. · Vaccine · 78
PDF
Candidate HIV-1 Tat vaccine development: from basic science to clinical trials
2006 · Barbara Ensoli, Valeria Fiorelli, et al. · AIDS · 73
Laboratory diagnostics for HIV infection
2010 · Stefano Buttò, Barbara Suligoi, et al. · Annali dell Istituto Superiore di Sanità · 71
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays.
2001 · O Schatz, P Monini, et al. · PubMed · 65
Sequence Conservation and Antibody Cross‐Recognition of Clade B Human Immunodeficiency Virus (HIV) Type 1 Tat Protein in HIV‐1–Infected Italians, Ugandans, and South Africans
2003 · Stefano Buttò, Valeria Fiorelli, et al. · The Journal of Infectious Diseases · 64
PDF
Efficient mucosal delivery of the HIV‐1 Tat protein using the synthetic lipopeptide MALP‐2 as adjuvant
2003 · Stefan Borsutzky, Valeria Fiorelli, et al. · European Journal of Immunology · 62
HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
2012 · Paolo Monini, Aurelio Cafaro, et al. · PLoS ONE · 60
PDF
Kaposi's sarcoma‐associated herpesvirus serology in Europe and Uuganda: Multicentre study with multiple and novel assays
2001 · Octavian Schatz, Paolo Monini, et al. · Journal of Medical Virology · 59
A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area
2001 · Diego Serraino, Luigi Toma, et al. · European Journal of Epidemiology · 58
Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production
1990 · C Locardi, C Petrini, et al. · Journal of Virology · 54
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
2000 · Aurelio Cafaro, Antonella Caputo, et al. · Journal of Medical Primatology · 52
Calibrated Real-Time PCR Assay for Quantitation of Human Herpesvirus 8 DNA in Biological Fluids
2002 · Francesco Broccolo, Giuseppe Locatelli, et al. · Journal of Clinical Microbiology · 45
HIV env glycoprotein shares a cross‐reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation
1987 · Alberto Beretta, Fabio Grassi, et al. · European Journal of Immunology · 42
Works count: 92
Citation count: 3,396
H-index: 29
I10-index: 55
Year
Topic
Type